2005
DOI: 10.1002/14651858.cd003774
|View full text |Cite
|
Sign up to set email alerts
|

Antiviral medication for preventing cytomegalovirus disease in solid organ transplant recipients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
0
0
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 0 publications
0
0
0
1
Order By: Relevance
“…Cytomegalovirus (CMV) is a member of the herpes virus family which can cause a mononucleosis like-illness and has a high serology prevalence of 60-100% in most communities [1,2]. Transmission occurs in a bimodal peak, the first peak in infancy likely related to placental transmission and horizontal spread amongst infants, and the second peak in young adulthood related to kissing and sexual transmission [3]. Following initial infection, CMV becomes latent and reactivation is well described in immunocompromised individuals such as those with advanced HIV infection, solid organ transplant, haematological and other malignancies, and undergoing chemotherapy and other immunosuppressants [3][4][5][6][7][8].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Cytomegalovirus (CMV) is a member of the herpes virus family which can cause a mononucleosis like-illness and has a high serology prevalence of 60-100% in most communities [1,2]. Transmission occurs in a bimodal peak, the first peak in infancy likely related to placental transmission and horizontal spread amongst infants, and the second peak in young adulthood related to kissing and sexual transmission [3]. Following initial infection, CMV becomes latent and reactivation is well described in immunocompromised individuals such as those with advanced HIV infection, solid organ transplant, haematological and other malignancies, and undergoing chemotherapy and other immunosuppressants [3][4][5][6][7][8].…”
Section: Introductionmentioning
confidence: 99%
“…Transmission occurs in a bimodal peak, the first peak in infancy likely related to placental transmission and horizontal spread amongst infants, and the second peak in young adulthood related to kissing and sexual transmission [3]. Following initial infection, CMV becomes latent and reactivation is well described in immunocompromised individuals such as those with advanced HIV infection, solid organ transplant, haematological and other malignancies, and undergoing chemotherapy and other immunosuppressants [3][4][5][6][7][8]. Reactivation can result in end organ disease including the retina, liver, lungs, central nervous system and gastrointestinal system [9].…”
Section: Introductionmentioning
confidence: 99%
“…4 Las infecciones respiratorias por citomegalovirus se ven favorecidas debido a que las células mesenquimales estromales del pulmón tienen una tasa elevada de infección, por lo que detectar la infección respiratoria por citomegalovirus de forma oportuna permite establecer una terapia eficaz y prevenir otras complicaciones. 5,6 La neumonía causada por citomegalovirus en pacientes trasplantados de médula ósea se ha identificado como una de las principales causas de mortalidad 7 y tienen mayor susceptibilidad a la infección entre los días 30 a 100 después del trasplante.…”
Section: Introductionunclassified